Loading…
Academic Journal
The place of metoprolol tartrate in the treatment of cardiovascular diseases
N. V. Romanova, I. V. Zhirov
Медицинский совет, Vol 0, Iss 4, Pp 16-19 (2016)
Saved in:
| Title | The place of metoprolol tartrate in the treatment of cardiovascular diseases |
|---|---|
| Authors | N. V. Romanova, I. V. Zhirov |
| Publication Year |
2016
|
| Source |
Медицинский совет, Vol 0, Iss 4, Pp 16-19 (2016)
|
| Description |
Since the beginning of the 1960s, beta-blockers have been number one medications in the treatment of cardiovascular diseases. A number of randomized controlled trials (RCTs) demonstrated positive effect of beta-blockers on morbidity and mortality [1]. It is difficult to overestimate the role of beta-blockers in modern cardiology. According to the results of a meta-analysis of 18 RCTs, administration of beta-blockers in patients with a risk of cardiovascular disease was associated with a reduction of the risk of stroke by 29%, coronary heart disease (CHD) by 7%, and chronic heart failure (CHF) by 29% [2]. In combination with ACE inhibitors, antiplatelet agents and statins, beta blockers helped to decrease mortality from acute coronary syndrome by 90% [3].
|
| Document Type |
article
|
| Language |
Russian
|
| Publisher Information |
Remedium Group LLC, 2016.
|
| Subject Terms | |
